Pasithea Therapeutics Corp. Common Stock (NASDAQ: KTTA) last traded at $0.430, down 3.93% on the session. The quote above updates while this page is open; the figures below are drawn from Pasithea Therapeutics Corp. Common Stock’s own filings and are restated only when a new one is published.
Pasithea Therapeutics Corp. Common Stock trades on NASDAQ under the ticker KTTA. Its market capitalisation is $14.36 million.
Valuation measures for Pasithea Therapeutics Corp. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $14.36M |
|---|---|
| Enterprise value | -$29.43M |
| Price / book | 0.29 |
| Beta | 1.38 |
Trailing-twelve-month figures tagged in Pasithea Therapeutics Corp. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$20.43M |
| EPS (TTM) | -$0.920 |
|---|
| Return on equity | -40.99% |
|---|
| Cash | $45.66M |
|---|
Range and volume for KTTA over the past 52 weeks.
| 52-week high | $2.06 |
|---|---|
| 52-week low | $0.281 |
| Volume | 40.6K |
| Average volume | 218.8K |
| Previous close | $0.448 |
Invest a chosen dollar amount in Pasithea Therapeutics Corp. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell KTTA.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.